Dr. Peter Tae-Jin Chang , MD
Ophthalmology โข Houston, TX
1977 Butler Blvd
Houston, TX 770304101
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 20, 2005; this date does not establish years in practice.
-
Published CMS data list 4,013 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 โ Established patient outpatient office visit: 891 service units.
- 92083 โ Exam of visual field with extended testing: 580 service units.
- G2211 โ Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 543 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 25 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 4,959 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Latanoprost โ 705 prescription fills, including refills.
- Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) โ 642 prescription fills, including refills.
- Timolol Maleate โ 435 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 39 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 80% of clinicians listed under Ophthalmology in Houston, TX (2024, 157 clinicians with data). Median for this group: 1,290. Middle half: 512 to 2,999.
More Medicare Part B services than 75% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,936 in 2020 to 4,013 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
1977 Butler Blvd
Houston, TX 770304101
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Baylor College Of Medicine. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Alabama School Of Medicine
1999
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
821 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $463,968 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $341,196 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
10,128 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$800,505 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $117,786.15 across 209 records.
By nature of payment (3 largest of 5)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $91,375.00 across 17 records.
- Travel and Lodging: $10,222.05 across 75 records.
- Food and Beverage: $7,139.10 across 113 records.
Reporting-company totals (3 largest of 12)
- ABBVIE INC.: $104,396.05 across 160 records.
- Glaukos Corporation: $7,440.61 across 8 records.
- NEW WORLD MEDICAL,INC.: $3,981.35 across 9 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
27 years (graduated 1999)
CMS Doctors and Clinicians data list 1999 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Chang has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Chang as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Houston and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 80% of clinicians listed under Ophthalmology in Houston, TX (2024, 157 clinicians with data). Median for this group: 1,290. Middle half: 512 to 2,999.
More Medicare Part B services than 75% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Medicare-allowed amount
A higher Medicare-allowed amount than 80% of clinicians listed under Ophthalmology in Houston, TX (2024, 157 clinicians with data). Median for this group: $164,118. Middle half: $46,762 to $332,685.
A higher Medicare-allowed amount than 75% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $211,752. Middle half: $85,606 to $415,016.
Paid by Medicare
A higher Medicare payment amount than 80% of clinicians listed under Ophthalmology in Houston, TX (2024, 157 clinicians with data). Median for this group: $121,752. Middle half: $34,732 to $241,863.
A higher Medicare payment amount than 75% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $151,943. Middle half: $60,170 to $302,740.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Ophthalmology in Houston, TX (2024, 175 clinicians with data). Median for this group: 655. Middle half: 221 to 2,095.
More Part D prescriptions than 90% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: 905. Middle half: 327 to 2,157.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Ophthalmology in Houston, TX (2024, 175 clinicians with data). Median for this group: $43,974. Middle half: $8,242 to $251,495.
A higher Part D drug cost than 95% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: $73,797. Middle half: $14,089 to $240,265.
262 active clinicians are listed under Ophthalmology with a practice address in Houston, TX (1,517 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Houston
1.9% of these 262 clinicians have the CMS telehealth indicator.
64.1% of these 262 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 37% from 2,936 in 2020 to 4,013 in 2024.
- 2020: 2,936
- 2021: 3,554
- 2022: 3,949
- 2023: 3,393
- 2024: 4,013
-
Medicare-allowed amount
Medicare-allowed amount increased 28% from $361,113 in 2020 to $463,968 in 2024.
- 2020: $361,113
- 2021: $467,278
- 2022: $537,579
- 2023: $416,716
- 2024: $463,968
-
Paid by Medicare
Paid by Medicare increased 32% from $259,232 in 2020 to $341,196 in 2024.
- 2020: $259,232
- 2021: $341,033
- 2022: $394,627
- 2023: $301,556
- 2024: $341,196
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 5,238 in 2020 and 4,959 in 2024.
- 2020: 5,238
- 2021: 5,190
- 2022: 4,823
- 2023: 4,900
- 2024: 4,959
-
30-day fills
30-day fills stayed about the same: 9,549 in 2020 and 10,128 in 2024.
- 2020: 9,549
- 2021: 9,781
- 2022: 9,284
- 2023: 9,577
- 2024: 10,128
-
Part D drug cost
Part D drug cost decreased 23% from $1,045,637 in 2020 to $800,505 in 2024.
- 2020: $1,045,637
- 2021: $1,059,421
- 2022: $998,818
- 2023: $990,632
- 2024: $800,505
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 30% from $90,734.54 in 2021 to $117,786.15 in 2025.
- 2021: $90,734.54
- 2022: $126,971.60
- 2023: $125,449.03
- 2024: $115,137.88
- 2025: $117,786.15
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 209 records totaling $117,786.15.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $8,500.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $5,950.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $5,950.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $5,950.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $5,950.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
LUMIGAN | General | $5,950.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $5,950.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $5,950.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $5,950.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $5,950.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $5,950.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $5,950.00 |
| Glaukos Corporation |
Consulting Fee
Cash or cash equivalent
|
Travoprost Intraocular Implant - iDose | General | $5,600.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $4,250.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $4,250.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $4,250.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $3,400.00 |
| NEW WORLD MEDICAL,INC. |
Honoraria
Cash or cash equivalent
|
Kahook Dual Blade | General | $2,500.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $1,275.00 |
| ABBVIE INC. |
Travel and Lodging
In-kind items and services
|
DURYSTA | General | $654.24 |
| NEW WORLD MEDICAL,INC. |
Honoraria
Cash or cash equivalent
|
Kahook Dual Blade | General | $600.00 |
| ABBVIE INC. |
Travel and Lodging
In-kind items and services
|
DURYSTA | General | $530.97 |
| ABBVIE INC. |
Travel and Lodging
In-kind items and services
|
DURYSTA | General | $530.97 |
| ABBVIE INC. |
Travel and Lodging
In-kind items and services
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $502.82 |
| ABBVIE INC. |
Travel and Lodging
In-kind items and services
|
LUMIGAN | General | $482.96 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
891 | 508 | $355.00 | $130.82 |
|
92083
Exam of visual field with extended testing
|
580 | 510 | $173.00 | $63.53 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
543 | 413 | $46.00 | $16.82 |
|
92133
Imaging of optic nerve
|
452 | 439 | $100.00 | $35.83 |
|
J7351
Injection, bimatoprost, intracameral implant, 1 microgram
|
330 | 25 | $594.75 | $204.33 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
259 | 214 | $252.00 | $92.81 |
|
92014
Established patient complete exam of visual system
|
169 | 165 | $344.00 | $127.08 |
|
92250
Photography of the retina
|
107 | 105 | $130.00 | $37.33 |
|
92020
Exam of the internal drainage system of eye
|
91 | 87 | $75.00 | $27.07 |
|
76519
Ultrasound scan to determine eye length and lens power
|
85 | 53 | $140.73 | $50.97 |
|
65855
Laser repair to improve eye fluid flow
|
80 | 59 | $1222.00 | $248.50 |
|
76514
Ultrasound scan of cornea to determine thickness
|
65 | 65 | $32.00 | $10.81 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
55 | 55 | $465.00 | $169.35 |
|
66984
Removal of cataract with insertion of prosthetic lens
|
47 | 34 | $2701.00 | $468.80 |
|
92136
Measurement of corneal curvature and depth of eye
|
34 | 28 | $88.00 | $31.55 |
|
66030
Injection of medication into eye
|
32 | 25 | $896.80 | $182.43 |
|
66180
Creation of shunt to improve eye fluid flow using tissue graft
|
28 | 25 | $5601.29 | $1140.18 |
|
68841
Insertion of drug delivery implant into tear duct of eye
|
27 | 23 | $162.00 | $16.43 |
|
66183
Insertion of eye fluid drainage device
|
26 | 22 | $5122.00 | $1044.72 |
|
66821
Removal of recurring cataract in lens capsule using a laser
|
23 | 19 | $1662.00 | $338.89 |
|
66991
Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye
|
21 | 18 | $3474.81 | $707.90 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
21 | 19 | $269.00 | $97.67 |
|
66174
Dilation of fluid outflow drainage within eye
|
17 | 13 | $3103.00 | $446.66 |
|
92134
Imaging of retina
|
17 | 16 | $111.00 | $40.30 |
|
65820
Incision to improve eye fluid flow
|
13 | 11 | $4093.00 | $779.67 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Latanoprost | Latanoprost | 705 | 52,311 | $9,201.18 | 229 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 642 | 48,845 | $14,216.00 | 181 |
| Timolol Maleate | Timolol Maleate | 435 | 29,699 | $4,696.39 | 132 |
| Brimonidine Tartrate | Brimonidine Tartrate | 290 | 18,257 | $26,329.14 | 105 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 289 | 16,986 | $55,109.61 | 93 |
| Prednisolone Acetate | Prednisolone Acetate | 266 | 12,890 | $14,502.67 | 140 |
| Lumigan | Bimatoprost | 230 | 15,172 | $118,170.78 | 80 |
| Combigan | Brimonidine Tartrate/Timolol | 210 | 10,599 | $79,888.25 | 60 |
| Moxifloxacin | Moxifloxacin Hcl | 188 | 3,473 | $3,413.63 | 146 |
| Travoprost | Travoprost | 170 | 11,357 | $36,591.66 | 58 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 152 | 4,086 | $2,513.64 | 114 |
| Brinzolamide | Brinzolamide | 125 | 7,203 | $30,335.20 | 36 |
| Dorzolamide Hcl | Dorzolamide Hcl | 117 | 7,054 | $2,502.85 | 37 |
| Doxycycline Hyclate | Doxycycline Hyclate | 113 | 7,712 | $4,026.52 | 36 |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 108 | 5,161 | $61,336.46 | 34 |
| Vyzulta | Latanoprostene Bunod | 107 | 4,906 | $45,150.77 | 29 |
| Simbrinza | Brinzolamide/Brimonidine Tart | 105 | 6,416 | $43,730.58 | 35 |
| Loteprednol Etabonate | Loteprednol Etabonate | 94 | 2,851 | $13,975.90 | 53 |
| Difluprednate | Difluprednate | 84 | 3,321 | $7,620.49 | 43 |
| Rhopressa | Netarsudil Mesylate | 73 | 4,116 | $45,071.48 | 23 |
| Restasis | Cyclosporine | 68 | 4,605 | $81,612.25 | 32 |
| Atropine Sulfate | Atropine Sulfate | 52 | 2,060 | $2,617.36 | 26 |
| Alphagan P | Brimonidine Tartrate | 45 | 2,204 | $23,555.77 | 14 |
| Bromfenac Sodium | Bromfenac Sodium | 34 | 932 | $4,522.34 | 22 |
| Fluorometholone | Fluorometholone | 34 | 2,215 | $3,087.73 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-11-06NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0009X
An ophthalmologist who specializes in the treatment of glaucoma and other disorders related to increased intraocular pressure and optic nerve damage. This specialty involves the medical and surgical treatment of these conditions.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20040714000331
TX
4688572001
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Baylor College Of Medicine
1502 Taub Loop, Houston, TX 770301608
Phone: 7138734900
Baylor College Of Medicine
7200 Cambridge St, Houston, TX 770304202
Phone: 7137982500
Baylor College Of Medicine
1504 Taub Loop, Houston, TX 770301608
Phone: 7138732000
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Optometrist
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Ophthalmology (license number reported to NPPES: TX L8645)
NPI status registered as active in NPPES database
Registered at 1977 BUTLER BLVD, HOUSTON, TX 770304101 (Tel: 7137986100)
Registered at PO BOX 4771, HOUSTON, TX 772104771 (Tel: (713) 798-6100)
Recorded as PETER CHANG, M.D.
Ophthalmology (license number reported to NPPES: TX L8645)
NPI status registered as active in NPPES database
Registered at 6560 FANNIN ST, SUITE 2200, HOUSTON, TX 770302761 (Tel: 7137986100)
Registered at PO BOX 4771, HOUSTON, TX 772104771 (Tel: 7137986100)
Recorded as PETER CHANG, M.D.
Ophthalmology (license number reported to NPPES: TX L8645)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Houston
- Dr. Hilary Beaver, MD
- Dr. Adeel Shaikh, MD
- Dr. Kavita Rao, MD
- Dr. Stephen Pflugfelder, MD
- Dr. David Brown, MD
- Federico Mattioli
Mailing Address
Po Box 4771
Houston, TX 772104771
Phone: 7137986100